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This paper describes the regressive course over one year of hypervascular nodules in a patient with Wilson’s disease. CT revealed
multiple, enhancing nodules (up to 3cm in diameter) detected in the liver in the early arterial phase after the administration
of intravenous contrast material. Most of these nodules became isodense in the portal venous phase. After one year of eﬃcient
therapy combining d-penicillamine and zinc acetate, most of the nodules had disappeared, while the liver contours had become
more regular. To our knowledge, the regression of large hypervascular nodules has not previously been reported in patients with
Wilson’s disease.
Copyright © 2009 Alcindo Pissaia Jr et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Wilson’s disease (WD) is an autosomal recessive disorder
characterized by defective copper excretion. WD occurs
worldwidewithan averageprevalenceof 10–30 aﬀectedindi-
vidualspermillionofthepopulation.Thegenethatisabnor-
mal in WD, ATP7B, encodes a metal-transporting ATPase
and was identiﬁed in 1993 [1, 2]. An absent or reduced
function of ATP7B protein leads to a decreased hepatocellu-
lar excretion of copper into bile, resulting in hepatic copper
accumulation and injury, an increased release of copper into
thebloodstreamanditsdepositioninvariousorgans,notably
the brain, kidneys, and cornea. A failure to incorporate cop-
per into ceruloplasmin results in lower blood levels of ceru-
loplasmin because of the reduced half-life of the apoprotein.
The clinical features of WD include hepatic abnormali-
ties, neurological defects (extrapyramidal features, seizures),
and psychiatric symptoms which are markedly heteroge-
neous, even among patients with the same mutations [3].
WD often presents with prominent liver disease in children
and young adults. However, hepatocellular carcinoma is a
rare complication of WD.
Liver transplantation is indicated in the event of decom-
pensated liver disease unresponsive to medical therapy and
in patients who present with fulminant hepatic failure [4,
5]. One-year survival following liver transplantation ranges
from 79% to 87%, and long term survival is excellent.
This paper describes the regressive course over one year
of hypervascular nodules in a patient with Wilson’s disease.
2.CaseReport
A 21-year-old man from Saudi Arabia, who had experienced
symptomsforoneyearpriortothediagnosisofWDandpre-
sented with cirrhosis possibly complicated by hepatocellular
carcinoma, was referred to our center with a view to liver
transplantation.
On admission, his vital signs were normal and his con-
sciousness was clear. Physical examination revealed jaundice,
moderate ascites, splenomegaly, and extrapyramidal rigidity.
Levels of total bilirubin (46µmol/L, N<17), direct
bilirubin (17µmol/L, N<2), aspartate aminotransferase
(77IU/L, N<40), and alanine aminotransferase (57IU/L,
N<40) were high. Gamma glutamyl transpeptidase levels
(50IU/L, N<80) were within the normal range. The
prothrombin rate (64%, INR 1.38) and albumin levels
(29g/L) were both low. Markers of hepatitis virus and
autoimmune hepatitis were all negative. Serum copper levels
were normal (13µmol/L) and serum ceruloplasmin levels2 Journal of Transplantation
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Figure 1: Arterial-phase axial CT images following the administration of contrast medium demonstrate multiple hyperdense nodules at the
early arterial phase. Nodules are not visible on unenhanced images.
were low (0.08g/L, N 0.17–0.70), while urinary copper levels
were high (2.2µmol/24 hours). The alphafetoprotein value
was 16.7µg/L.
Abdominal ultrasonography (US) and computed tomog-
raphy (CT) scans revealed liver cirrhosis and splenomegaly.
US showed that the liver contours were irregular and
its echogenicity was increased, with multiple, hypo- and
hyperechoic nodules. CT scans were performed using a 64-
detector dual-source DE scanner (Somatom DeﬁSiemens
Medical Solutions, Forchheim, Germany), with a four-phase
technique that included the acquisition of nonenhanced
images and a three-phase intravenous contrast material-
enhanced CT during the hepatic arterial, portal venous,
and delayed phases. Scanning delays were 20–28 seconds
for arterial phase imaging, 60–70 seconds for portal venous
phase imaging, and 300 seconds for delayed imaging phase.
TheCT scansrevealed a liverof reduced volume withmarked
contour irregularity consistent with chronic liver disease.
Multiple hypervascular nodules (the largest being 3cm in
diameter) were depicted at the arterial phase under contrast-
enhanced CT (Figure 1). All nodules became isoattenuating
or hypoattenuating to the surrounding liver parenchyma
during either the portal venous phase or the delayed phase.
Slit-lamp examination revealed Kayser-Fleischer rings
on the patient’s cornea. Cerebral MR imaging was per-
formed using a 1.5 T system (Signa, GE Medical Systems,
Milwaukee, Wis.) equipped with the standard head coil.
MRsequencesincludedtransverse,unenhancedT1-weighted
images (TR/TE, 580/20; 5mm section thickness; interslice
gap, 1.5mm; ﬁeld of view, 24 × 18), transverse T2-weighted
fast spin-echo images (3.800/98; 5mm section thickness;
interslice gap, 1.5mm; ﬁeld of view, 24 × 24), transverse
FLAIR sequences (9.802/156, 5mm section thickness; inter-
slice gap, 1.5mm; ﬁeld of view, 24 × 24), diﬀusion-weighted
images, and 3D T1-weighted after IV contrast injection
(gadopentetate dimeglumine, 0.1mmol/kg) with multipla-
nar reconstructions. T1-weighted, T2-weighted, diﬀusion-
weighted,andFlairimagesrevealedincreasedsignalintensity
in the putamen. No abnormalities were found in the thalami,
caudate and globus pallidus, cortical white matter, the pons,
the midbrain, or cerebellum. Since no other recognized case
was available in the patient’s family, a direct mutation anal-
ysis was performed and revealed a compound heterozygous
for WD (Ser744Pro substitution and 4193 delc deletion).
D-penicillamine (Trolovol, Dexo) was initiated at
300mg/d and then increased to 1200mg/d in 2 dividedJournal of Transplantation 3
intakes. Pyridoxine (35mg) (vitamin B1B6, Bayer) and
zinc acetate dihydrate (Wilzin, Orphan Europe) (100mg/d)
were added. Tolerance was excellent, without any signiﬁcant
modiﬁcations to the blood count and creatinine levels, and
without signiﬁcant proteinuria or leucocyturia. After 30 days
of treatment, 24-hour urinary copper excretion was 37µmol.
One year after treatment initiation, physical examination
revealed neither jaundice or ascites. Splenomegaly and
extrapyramidal rigidity persisted. Total bilirubin (26IU/L),
direct bilirubin (8IU/L), aspartate aminotransferase
(42IU/L), alanine aminotransferase (41IU/L), gamma
glutamyl transpeptidase (38IU/L), prothrombin rate (72%),
and albumin (32g/L) values had all improved. Three-
phase abdominal CT revealed increased hepatic volume
and reduced contour irregularity. At the arterial phase, a
dramatic reduction in the number and size of nodules (the
largest being 1cm in diameter) and hyperdense nodules
was observed (Figure 1). All these nodules became isodense
during the portal venous phase.
3. Discussion
Imaging ﬁndings in cirrhotic patients include an increased
echogenicity of the liver, the irregularity of contours, and
atrophied lobes or segments. During one study of 33 WD
patients, US examination revealed disorders aﬀecting the
hepatic echotexture (29 cases), changes to splenic dimen-
sions (21 cases), liver shrinkage (10 cases), cholelithiasis
(8 cases), and ascites (1 case) [6]. Disorders aﬀecting liver
echotexture displayed diﬀerent patterns, ranging from slight
to severe changes in hepatic echogenicity, associated with
anatomical distortions of the liver, such as alterations in
outline and a decrease in dimensions [6]. These ﬁndings are
indistinguishable from those of cirrhosis due to other causes.
Multiple round foci of decreased echogenicity resembling
metastatic liver disease [7] and hyperechogenic nodules [8]
have also been reported on rare occasions.
It is generally accepted that CT of the liver oﬀers little
information regarding the diagnosis or management of WD.
Nodularity in the liver has only been observed in a few WD
patients [9, 10]. Multiple hyperdense areas in the liver on
unenhanced CT images were reported in a 2-year-old child
[11]. These lesions were hyperintense on T1-weighted, and
hypointense on T2-weighted, MRI images. In a 12-year-old
child, nodules were only detectable after the administration
of contrast material for CT [8]. Large hypervascular nodules
may be dysplastic or neoplastic lesions. More rarely, they
correspond to regenerative nodules. In the series of Akhan,
the arterial enhancing nodules were secondary to dysplastic
changes [8], and the lesions were best appreciated on
early arterial phase images following the administration of
intravenous contrast medium. Low-grade dysplastic nodules
are normally supplied by the portal vein and therefore are
isointense to liver during the arterial phase. The signal inten-
sity characteristics of some high-grade dysplastic nodules,
which receive increasing supply from the hepatic artery, may
overlap with those of hepatocellular carcinoma [12]. During
another study, arterial phase enhancementof nodular lesions
in a cirrhotic liver during CT was interpreted as hepato-
cellular carcinoma [13]. Indeed, size larger than 2cm and
rapidintervalgrowthintermsofarterialhypervascularityare
the usual criteria favoring malignancy [12]. However, most
patient series have shown that liver carcinogenesis is reduced
in WD when compared to other causes of cirrhosis [14]. The
blood supply of regenerative nodules is largely dependent
from the portal vein, with minimal contribution from the
hepatic artery. This vascular supply dynamic explains why
there is no enhancement during the hepatic arterial phase on
CT or MR images, although arterial phase enhancement in
regenerativenoduleshasbeendescribedandcanbemistaken
for hepatocellular carcinoma [15]. Liver biopsy is usually
performed to distinguish between dysplastic or neoplastic
nodules and regenerative nodules, although sampling errors
are frequent.
In our case, the liver biopsy was refused by the patient. A
diagnosisofregenerativeordysplasticnoduleswasproposed,
and the patient was regularly monitored while on the
waiting list for liver transplantation, without liver biopsy.
Theregressionofthesenodulesafteronlyoneyearofeﬃcient
therapy and improvements in liver function parameters led
to the patient’s removal from the waiting list.
A reduction in copper accumulation under d-penici-
llamine therapy may reduce the inﬂammatory process and,
in the long term, lead to a regression of ﬁbrosis. In addition,
zinc salts have been shown to inhibit the production
of oxygen-activated species and reduce lipid peroxidation
[16]. We can thus hypothesize that combined therapy
with d-penicillamine and zinc salts acted synergistically to
improve the ﬁbrogenic and dysplastic processes. Alterna-
tively, changes in hemodynamics of the patient due to the
successful therapy are possible. Finally, it can not be ruled
out that attenuation of contrast on the second CT scan,
in comparison with the ﬁrst one, may play a role in the
diﬀerences observed.
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